About
Platform
Products
bCap 1
eCap 1
Lab
Team
Partnering & Licensing
Careers
Openings
News
Contact
AI Generates Unprecedented Diversity of AAV Capsids
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies
Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
The 2020 National Xconomy Awards Winner – Startup of the Year
Dyno advances AI-powered gene therapy
Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy
Spun out of George Church’s lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze
